Fehrenbacher L, Spira A, Ballinger M, Kowanetz M, Vansteenkiste J, Mazieres J, et al. Atezolizumab versus docetaxel for patients with previously treated non -small -cell lung cancer (POPLAR): a multicentre, open -label, phase 2 randomised controlled trial . Lancet.